Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Galena Biopharma In (GALE)

0.3869 -0.0071 (-1.8020%)

10/17/2017  4:00pm

Open:

0.3916

Pre. Close:

0.3940

High:

0.3940

Low:

0.3820

Volume:

170,157

Market Cap:

14.86M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.4 - 0.41

0.41 - 0.42

Low:

0.36 - 0.37

0.37 - 0.38

Close:

0.38 - 0.39

0.39 - 0.41

Technical analysis  (as of: 2017-10-17 4:36:43 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.48     One year: 0.53

Support:

Support1: 0.34    Support2: 0.28

Resistance:

Resistance1: 0.41    Resistance2: 0.45

Pivot:

0.39

Moving Averages:

MA(5): 0.39     MA(20): 0.38

MA(100): 0.47     MA(250): 0.92

MACD:

MACD(12,26): 0.01     Signal(12,26,9):

%K %D:

%K(14,3): 36.97     %D(3): 41.66

RSI:

RSI(14): 50.47

52-Week:

High: 6.9760  Low: 0.2568  Change(%): 43.3

Average Vol(K):

3-Month: 67904  10-Days 68029

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
GALE has closed above bottom band by 46.1%. Bollinger Bands are 14.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 11 Aug 2017 18:00:00 GMT
Galena Biopharma (GALE) Discusses Galena Biopharma and SELLAS Life Sciences ...

Tue, 08 Aug 2017 09:56:15 GMT
Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group

Thu, 05 Oct 2017 21:22:30 GMT
Galena Biopharma Inc. (GALE) Moves Higher on Volume Spike for October 05

Wed, 20 Sep 2017 14:28:00 GMT
How Does Investing In Galena Biopharma Inc (GALE) Impact Your Portfolio?

Thu, 28 Sep 2017 11:03:45 GMT
Galena Biopharma Announces Completion of Enrollment in Two NeuVax ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

Shares Float (M)

25.13

% Held by Insiders

4.46

% Held by Institutions

28.27

Shares Short (K)

4610

Shares Short Prior Month (K)

4560

Stock Financials

EPS

-1.520

EPS Est. Current Year

-0.590

EPS Est. Next Year

-0.840

EPS Est. Next Quarter

-0.150

Forward EPS

-0.840

Book Value (p.s.)

0.510

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-22.0

Return on Equity (ttm)

-79.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.611

Qtrly Earnings Growth

Operating Cash Flow (M)

-40.17

Levered Free Cash Flow (M)

-0.99

FoxReading.com

Valuation

P/E

-0.25

P/E Growth Ratio

-0.02

P/BV

0.76

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-11-14

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.